Neri, Jerry B.

HRN: 28-75-48  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/27/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/27/2026
04/02/2026
PO
500MG
Q8
ASCITIS
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: